Dna X (SONM) Net Cash Flow (2018 - 2025)
Dna X filings provide 8 years of Net Cash Flow readings, the most recent being -$834000.0 for Q4 2025.
- On a quarterly basis, Net Cash Flow rose 77.56% to -$834000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.0 million, a 0.35% change, with the full-year FY2025 number at -$4.0 million, changed 0.35% from a year prior.
- Net Cash Flow hit -$834000.0 in Q4 2025 for Dna X, down from $131000.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $7.5 million in Q2 2022 to a low of -$8.2 million in Q1 2021.
- Median Net Cash Flow over the past 5 years was -$470000.0 (2023), compared with a mean of -$1.0 million.
- Biggest five-year swings in Net Cash Flow: soared 207.25% in 2022 and later tumbled 2126.21% in 2025.
- Dna X's Net Cash Flow stood at $1.0 million in 2021, then tumbled by 316.16% to -$2.3 million in 2022, then surged by 82.31% to -$400000.0 in 2023, then crashed by 829.25% to -$3.7 million in 2024, then surged by 77.56% to -$834000.0 in 2025.
- The last three reported values for Net Cash Flow were -$834000.0 (Q4 2025), $131000.0 (Q3 2025), and -$109000.0 (Q2 2025) per Business Quant data.